State Street Corp Sells 24,300 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT)

State Street Corp reduced its position in shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) by 18.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 105,202 shares of the company’s stock after selling 24,300 shares during the period. State Street Corp’s holdings in ClearPoint Neuro were worth $1,179,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Point72 DIFC Ltd acquired a new stake in shares of ClearPoint Neuro during the second quarter worth $32,000. Verition Fund Management LLC bought a new position in ClearPoint Neuro during the third quarter worth about $123,000. XTX Topco Ltd raised its stake in ClearPoint Neuro by 11.6% in the 2nd quarter. XTX Topco Ltd now owns 13,010 shares of the company’s stock worth $70,000 after purchasing an additional 1,353 shares in the last quarter. Oppenheimer & Co. Inc. bought a new stake in ClearPoint Neuro in the 3rd quarter valued at about $156,000. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of ClearPoint Neuro during the 2nd quarter worth approximately $175,000. 30.08% of the stock is currently owned by institutional investors.

ClearPoint Neuro Trading Up 1.0 %

Shares of CLPT opened at $15.54 on Friday. ClearPoint Neuro, Inc. has a 12 month low of $5.11 and a 12 month high of $17.47. The firm’s 50 day moving average is $13.46 and its 200-day moving average is $10.93. The stock has a market capitalization of $428.67 million, a PE ratio of -22.52 and a beta of 1.08.

ClearPoint Neuro Profile

ClearPoint Neuro, Inc operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain.